ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly u.S. portfolio average net price realized (% of list price after rebates & discounts) (%)
Lilly 2025 Sustainability Highlights Report (U.S. Pricing Transparency)
Latest, FY2025
39.0%
Period ended Dec 31, 2025
Change on a year earlier
-1.0 pts
40.0% in FY2024
History
2 years
Since FY2024
Sources
1
Lilly 2025 Sustainability Highlights Report
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. portfolio average net price realized (% of list price after rebates & discounts) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39.0% | -1.0 pts | Lilly 2025 Sustainability Highlights Report ↗ |
| FY2024 | Dec 31, 2024 | 40.0% | – | Lilly 2025 Sustainability Highlights Report ↗ |
Cite this data
StockData. (2026). Eli Lilly U.S. portfolio average net price realized (% of list price after rebates & discounts) (%), annual FY2024–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/pricing_us_net_pct_of_list
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.